These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8691925)
1. The SWORD of Damocles. Sanderson J Lancet; 1996 Jul; 348(9019):2-3. PubMed ID: 8691925 [No Abstract] [Full Text] [Related]
2. Antiarrhythmic trials: a decade of growth. Kanjwal MY Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848 [No Abstract] [Full Text] [Related]
3. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Gambhir DS Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817 [No Abstract] [Full Text] [Related]
4. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial. Jafri SM; Borzak S; Goldberger J; Gheorghiade M Prog Cardiovasc Dis; 1998; 41(1):65-70. PubMed ID: 9717860 [TBL] [Abstract][Full Text] [Related]
5. [Role of electrophysiology in the prognosis and therapy of cardiomyopathies]. Laurenzi F; Avella A; Adinolfi E; Dini P G Ital Cardiol; 1999 Oct; 29(10):1190-4. PubMed ID: 10546132 [No Abstract] [Full Text] [Related]
6. Should post-infarction asymptomatic ventricular arrhythmias be treated? The need for caution. Sleight P Eur Heart J; 1995 Jul; 16 Suppl E():49. PubMed ID: 8542884 [No Abstract] [Full Text] [Related]
7. Class III antiarrhythmic action: the way forward? Campbell TJ Med J Aust; 1993 Jun; 158(11):732-3. PubMed ID: 8341184 [No Abstract] [Full Text] [Related]
11. [Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents]. Fujiki A Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):253-60. PubMed ID: 16536075 [No Abstract] [Full Text] [Related]
12. Amiodarone: a late comer. Futterman LG; Lemberg L Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203 [TBL] [Abstract][Full Text] [Related]
13. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials. Malik M; Camm AJ Lancet; 1997 Jun; 349(9067):1767-8. PubMed ID: 9193398 [No Abstract] [Full Text] [Related]
14. Beta-blockers for ventricular arrhythmias: have we underestimated their value? Campbell TJ Aust N Z J Med; 1996 Oct; 26(5):689-96. PubMed ID: 8958366 [No Abstract] [Full Text] [Related]
15. Beta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT, and EMIAT. Cardiac Arrhythmia Suppression Trial. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. European Myocardial Infarct Amiodarone Trial. Kennedy HL Am J Cardiol; 1997 Nov; 80(9):1208-11. PubMed ID: 9359552 [No Abstract] [Full Text] [Related]
16. Sotalol for cardiac arrhythmias. Med Lett Drugs Ther; 1993 Apr; 35(893):27-8. PubMed ID: 8450806 [No Abstract] [Full Text] [Related]
17. [Death is still a death. Does it matter if the cause is myocardial infarction or arrhythmia?]. Werkö L Lakartidningen; 1998 Jan; 95(4):246-8. PubMed ID: 9469947 [No Abstract] [Full Text] [Related]